Parkside Financial Bank & Trust’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
DSCM
SFM
AC
SBH
Parkside Financial Bank & Trust's ANGO Position: Q2 2025 in Review
Parkside Financial Bank & Trust sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 45 shares — an estimated $423 sold.
Parkside Financial Bank & Trust first reported a position in ANGO in Q1 2017 and held it in 27 quarters. The position peaked at $5K in Q4 2021. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.
- Parkside Financial Bank & Trust reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 45 AngioDynamics shares in Q2 2025, an estimated $423.
- Parkside Financial Bank & Trust first reported a position in AngioDynamics in Q1 2017 and held it in 27 quarters.
- Parkside Financial Bank & Trust's AngioDynamics position peaked at $5K in Q4 2021.
- 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.